Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» hepatitis C
hepatitis C
Why Idenix Pharmaceuticals Shares Were Put in Time-Out Again
Motley Fool
Sat, 06/22/13 - 09:46 am
Idenix
IDX20963
hepatitis C
Idenix says FDA wants more safety data on experimental hepatitis C drug, delaying human trials
Yahoo/AP
Fri, 06/21/13 - 09:16 am
Idenix
FDA
hepatitis C
IDX20963
Abbott hepatitis C genotyping test approved by FDA
Yahoo/Fly on the Wall
Thu, 06/20/13 - 12:17 pm
Abbott Laboratories
genotyping text
hepatitis C
FDA
Gilead's Potential Megablockbuster Raises the Bar
Motley Fool
Mon, 06/17/13 - 09:24 am
Gilead
sofosbuvir
hepatitis C
AbbVie says it could beat Gilead to huge market for hep C drugs
Fierce Pharma
Fri, 06/14/13 - 10:34 am
AbbVie
Gilead
hepatitis C
Consider Biotech Gilead Sciences Because Of Atripla, Sofosbuvir And Great R&D
Seeking Alpha
Fri, 06/14/13 - 08:27 am
sofosbuvir
Atripla
Gilead
HIV
R&D
hepatitis C
Inside HCV: An Interview with Janssen
Motley Fool
Thu, 06/13/13 - 10:54 am
hepatitis C
Janssen
Gilead
JNJ
Vertex
simeprevir
sofosbuvir
Gilead Announces U.S. FDA Priority Review Designation for Sofosbuvir for the Treatment of Hepatitis C
Yahoo/BusinessWire
Sat, 06/8/13 - 10:10 am
Gilead Sciences
sofosbuvir
hepatitis C
hepatitis
Drugs Go From Hit to Dud in Two Years in Hepatitis Race
Bloomberg
Mon, 06/3/13 - 10:27 am
hepatitis C
Merck
Gilead
Vertex Pharmaceuticals
JNJ
Medivir
Bristol-Myers Squibb
Idenix Pharma Initiates Phase II Study
Yahoo/Zacks
Sat, 06/1/13 - 12:06 pm
Idenix
hepatitis C
hepatitis
samatasvir
IDX719
simeprevir
TMC435
JNJ
The Race For Oral HCV?
Seeking Alpha
Fri, 05/31/13 - 12:57 pm
AbbVie
Gilead
JNJ
Merck
Vertex Pharmaceuticals
hepatitis C
Will Hepatitis C Become The Next Battleground Over Compulsory Licenses?
Pharmalot
Fri, 05/31/13 - 12:43 pm
hepatitis C
compulsory licenses
Gilead's sofosbuvir gets EMA validation, now under assessment
The Fly on the Wall
Wed, 05/22/13 - 10:16 am
Gilead
Europe
sofosbuvir
hepatitis C
Racing Toward the Next Hepatitis C Drug Approval
Motley Fool
Wed, 05/15/13 - 09:06 am
hepatitis C
JNJ
Gilead
Merck
Roche
Vertex Pharmaceuticals
[video]FDA Prioritizes New Hepatitis C Drug
Motley Fool
Tue, 05/14/13 - 09:04 am
FDA
JNJ
hepatitis C
simeprevir
Gilead's Hepatitis C Drug Sofosbuvir Offers Upside
Seeking Alpha
Thu, 05/9/13 - 09:40 am
hepatitis C
sofosbuvir
Gilead
FDA ‘breakthrough’ tab on AbbVie Hepatitis C drug leaves shares flat
Marketwatch
Mon, 05/6/13 - 11:34 am
FDA
breakthrough therapies
hepatitis C
AbbVie
Gilead's HCV Drug Pipeline Outshines Weak Q1 Results
Investors.com
Fri, 05/3/13 - 08:54 am
earnings
Gilead
hepatitis C
Gilead combo hepatitis C pill shown effective in small trial
Reuters
Thu, 05/2/13 - 10:28 am
hepatitis C
Gilead
ledipasvir
sofosbuvir
Gilead-Bristol Hepatitis C Drug Combo Cures All in Study
Bloomberg
Mon, 04/29/13 - 10:26 am
Gilead
Bristol-Myers Squibb
hepatitis C
declatasvir
sofosbuvir
Pages
« first
‹ previous
…
28
29
30
31
32
33
34
35
36
…
next ›
last »